PHE Paper Selected As Value in Health Editor's Choice Article
We are proud to announce that a recently published paper with PHE co-authors, “Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations,” has been selected to be an Editors’ Choice article in the June 2017 issue of Value in Health.
To see the complete article as it appears online, please click here.
By: Jason Shafrin, PhD Sr. Director, Policy and Economics and Jacki Chou, MPL Senior Director, Policy and Economics The recent announcement that CVS Caremark will use value-based metrics to inform formulary design at first appears a step in the right direction. However, using value measurements from a single nongovernmental organization—the Institute for Clinical and Economic Review (ICER)—based on a limited picture of treatment value may be problematic. Using this single assessment of value in an effort solely to exclude drugs from a major insurance formulary is even more worrisome and fails to recognize the heterogeneity in patient clinical needs and preferences.